Human Complement Component C5a DuoSet ELISA DY2037 from R&D Systems, a Bio-Techne Brand

Product Specs
ItemHuman Complement Component C5a DuoSet ELISA
CompanyR&D Systems, a Bio-Techne Brand
Price $890.00Supplier Page View Supplier Product Page
Catalog NumberDY2037
Quantity1 Kit (for 15 Plates)
ApplicationsELISA
Detection Range31.20 - 2000 pg/mL
ReactivityHuman
Detection TargetComplement Component C5a
StorageStore the unopened product at 2 - 8 °C. Do not use past expiration date
NCBI Full Gene Namecomplement C5
NCBI Gene AliasesC5D, C5a, C5b, CPAMD4, ECLZB

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) tRF3a-MetCAT promotes EGFR-targeted therapeutic resistance through the TRIM21-STAT1-C5a axis in lung adenocarcinomaResearch (Wash D C)October 7, 2025Yuchen Zhang, Pingjing Zhou, Yifan Guo, Hongyu Zhang, Jie Gu, Di Ge, Guangyin Zhaodetermined through a standardized enzyme-linked immunosorbent assay procedure supplied by R&D Systems (DY2037). Following the protocol, a microplate reader measured absorbance at 450 nm. Immunofluorescence Cells

(2) Enhanced immunocompatibility and hemocompatibility of nanomedicines across multiple species using complement pathway inhibitorsSci AdvJuly 11, 2025Yue Li, Sarah Jacques, Hanmant Gaikwad, Morgan Nebbia, Nirmal K. Banda, V. Michael Holers, Stephen A. Tomlinson, Robert I. Scheinman, Andrew Monte, Laura Saba, et al.measured using a Human Complement Component C5a DuoSet enzyme-linked immunosorbent assay (ELISA) kit (DY2037, BioTechne) according to the manufacturer’s protocol (1:100 to 1:400 plasma dilution). Plates were read

(3) Thrombospondin-1 inhibits alternative complement pathway activation in antineutrophil cytoplasmic antibody-associated vasculitisThe Journal of clinical investigationJuly 1, 2025Konwar S, Schroda S, Rogg M, Kleindienst J, Decker EL, Pohl M, Zieger B, Panse J, Wang H, Grosse R, et al.incubation, the 2 samples were mixed, and the amount of released C5a was quantified by ELISA (R&D Systems, DY2037). MAC formation assay. The ability of TSP-1 to inhibit MAC formation on the surface of sheep erythrocytes

(4) The C5a/C5aR1 Axis Promotes Migration of Tolerogenic Dendritic Cells to Lymph Nodes, Impairing the Anticancer Immune ResponseCancer immunology researchMarch 4, 2025Senent Y, Remírez A, Repáraz D, Llopiz D, Celias DP, Sainz C, Entrialgo-Cadierno R, Suarez L, Rouzaut A, Alignani D, et al.

(5) β-1,6-Glucan plays a central role in the structure and remodeling of the bilaminate fungal cell walleLifeDecember 5, 2024Bekirian C, Valsecchi I, Bachellier-Bassi S, Scandola C, Guijarro JI, Chauvel M, Mourer T, Gow NAR, Aimanianda VK, d'Enfert C, et al.

(6) IgM anti-GM2 antibodies in patients with multifocal motor neuropathy target Schwann cells and are associated with early onsetJournal of neuroinflammationApril 17, 2024Budding K, Bos JW, Dijkxhoorn K, de Zeeuw E, Bloemenkamp LM, Zekveld EM, Groen EJN, Jacobs BC, Huizinga R, Goedee HS, et al.

(7) Enzymatic conversion of human blood group A kidneys to universal blood group ONat CommunMarch 30, 2024Serena MacMillan, Sarah A. Hosgood, Léonie Walker-Panse, Peter Rahfeld, Spence S. Macdonald, Jayachandran N. Kizhakkedathu, Stephen G. Withers, Michael L. NicholsonSoftware Suite (Biolegend, San Diego, CA, USA). C5a and sC5b-9 measurements Perfusate levels of C5a (DY2037; R&D Systems, MN, USA) and sC5b-9 (558315; BD Biosciences, NJ, USA) were measured with ELISAs following

(8) Using the Traditional Ex Vivo Whole Blood Model to Discriminate Bacteria by Their Inducible Host ResponsesBiomedicinesMarch 25, 2024Chick HM, Rees ME, Lewis ML, Williams LK, Bodger O, Harris LG, Rushton S, Wilkinson TS.

(9) Downregulation of complement factor H attenuates the stemness of MDA‑MB‑231 breast cancer cells via modulation of the ERK and p38 signaling pathwaysOncology lettersDecember 1, 2023Park SY, Eum DY, Jin Y, Lee CY, Shim JW, Choi SH, Park SJ, Heo K, Choi YJ.control. ELISA ELISAs were performed on the cells using the Human Complement Component C5a DuoSet ELISA kit (cat. no. DY2037; R&D Systems, Inc.) according to the manufacturer's protocols. The optical density of the samples at

(10) Impaired gut microbiota-mediated short-chain fatty acid production precedes morbidity and mortality in people with HIVCell reportsNovember 28, 2023Sereti I, Verburgh ML, Gifford J, Lo A, Boyd A, Verheij E, Verhoeven A, Wit FWNM, Schim van der Loeff MF, Giera M, et al.,R&D Systems,DY807 Human IL-6 DuoSet ELISA,R&D Systems,DY206 Human Complement Component C5a DuoSet ELISA,R&D Systems,DY2037 Human FABP2/I-FABP DuoSet ELISA,R&D Systems,DY3078 KAPA library quantification Complete kit (Universal),Roche,KK4824 MiSeq

(11) Inhibition of cleavage of human complement component C5 and the R885H C5 variant by two distinct high affinity anti-C5 nanobodiesThe Journal of biological chemistryAugust 1, 2023Struijf EM, De la O Becerra KI, Ruyken M, de Haas CJC, van Oosterom F, Siere DY, van Keulen JE, Heesterbeek DAC, Dolk E, Heukers R, et al.

(12) C5aR1 signaling triggers lung immunopathology in COVID-19 through neutrophil extracellular trapsThe Journal of clinical investigationJune 15, 2023Silva BM, Gomes GF, Veras FP, Cambier S, Silva GV, Quadros AU, Caetité DB, Nascimento DC, Silva CM, Silva JC, et al.performed using, respectively, the human complement component C5a duoset ELISA kit from R&D Systems (DY2037), the MicroVue Bb plus fragment EIA kit from Quidel (A027), and the Complement C3a human ELISA kit from

(13) Impact of neutrophil extracellular traps on fluid properties, blood flow and complement activationFrontiers in ImmunologyDecember 16, 2022Antonia Burmeister, Sabine Vidal-y-Sy, Xiaobo Liu, Christian Mess, Yuanyuan Wang, Swagata Konwar, Todor Tschongov, Karsten Häffner, Volker Huck, Stefan W. Schneider, et al.(24). ELISA Complement activation was quantified by C5a ELISA (Human Complement Component C5a DuoSet ELISA, DY2037 R&D Systems, Inc., USA). The ELISA was performed according to the manufactures protocol with modification.

(14) Soluble MAC is primarily released from MAC-resistant bacteria that potently convert complement component C5eLifeAugust 10, 2022Doorduijn DJ, Lukassen MV, van 't Wout MFL, Franc V, Ruyken M, Bardoel BW, Heck AJR, Rooijakkers SHM.enzyme-linked immunosorbent assays (ELISAs) on Nunc Maxisorp ELISA plates. For C5a, a sandwich-ELISA kit was used (R&D Systems, DY2037), which includes two mouse monoclonal C5a antibodies that specifically detect C5a and not native C5. For

(15) PEGylated Polyester Nanoparticles Trigger Adverse Events in a Large Animal Model of Trauma and in Naı̈ve Animals: Understanding Cytokine and Cellular Correlations with These EventsACS NanoJuly 26, 2022Nuzhat Maisha, Chhaya Kulkarni, Narendra Pandala, Rose Zilberberg, Leasha Schaub, Leslie Neidert, Jacob Glaser, Jeremy Cannon, Vandana Janeja, Erin B. Lavikobtained from Fisher Scientific. We monitored Complement protein C5a using a C5a human ELISA duo kit (DY2037) obtained from R&D Systems (Minneapolis, MN). Zymosan was obtained from Sigma Aldrich. Dulbecco’s phosphate-buffered saline

(16) Evaluation of Patients with Vaccine Allergies Prior to mRNA-Based COVID-19 VaccinationVaccinesJune 27, 2022Lim XR, Tan JWL, Chan GYL, Hou J, Xie L, Goh VHL, Boon J, Lee SSM, Teo CM, Tan SC, et al.

(17) Intracellular complement C5a/C5aR1 stabilizes β-catenin to promote colorectal tumorigenesisCell reportsMay 31, 2022Ding P, Xu Y, Li L, Lv X, Li L, Chen J, Zhou D, Wang X, Wang Q, Zhang W, et al.

(18) Secondary Complement Deficiency Impairs Anti-Microbial Immunity to Klebsiella pneumoniae and Staphylococcus aureus During Severe Acute COVID-19Frontiers in ImmunologyApril 27, 2022Youssif M. Ali, Nicholas J. Lynch, Priyanka Khatri, Ifeoluwa E. Bamigbola, Andrew C. Y. Chan, Munehisa Yabuki, Gregory A. Demopulos, Jonathan L. Heeney, Sumita Pai, Helen Baxendale, et al.Products Circulating C5a and sC5b-9 levels were measured using a sandwich ELISA kit supplied by R&D systems (Cat. No. DY2037) and (BD OptEIA Human C5b-9 ELISA set). Complement C3 and C4 levels were measured using Abcam C3 and

(19) A Factor H-Fc fusion protein increases complement-mediated opsonophagocytosis and killing of community associated methicillin-resistant Staphylococcus aureusPloS oneJanuary 1, 2022Sage MAG, Cranmer KD, Semeraro ML, Ma S, Galkina EV, Tran Y, Wycoff KL, Sharp JA.

(20) Persistence of High Levels of Serum Complement C5a in Severe COVID-19 Cases After Hospital DischargeFrontiers in ImmunologyNovember 18, 2021Yaiza Senent, Susana InogÃ©s, AscensiÃ³n LÃ³pez-DÃaz de Cerio, Andres Blanco, Arantxa Campo, Francisco Carmona-Torre, Patricia Sunsundegui, Antonio GonzÃ¡lez-MartÃn, Daniel Ajona, Marcin OkrÃ³j, et al.anti-C5a capture and detection antibodies from the Human Complement Component C5a DuoSet ELISA kit (DY2037, R&D Systems). C5b-9 levels, routine laboratory markers and pro-inflammatory cytokines IFNγ and IL1α

Be the First to Write a Review!

Complement Component C5a ELISA

Human Complement Component C5a DuoSet ELISA

Human Complement Component C5a DuoSet ELISA from R&D Systems, a Bio-Techne Brand

R&D Systems, a Bio-Techne Brand

Citations (44)

Reviews

Human Complement Component C5a DuoSet ELISA from R&D Systems, a Bio-Techne Brand

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map